Empatica Care vs MyLongCOVID

The Care App is used by patients and trial participants to facilitate remote health data collection when used with Empatica’s medical-grade EmbracePlus wearable. The Care App receives physiological data collected by EmbracePlus via Bluetooth and transmits this data to the Cloud for review and download by a professional. Key features include: * Live status check of the system * Continuous, automated physiological data streaming * Wearing time indicator to safeguard adherence * Smart troubleshooting and notifications * Easy onboarding for EmbracePlus * Secure, de-identified login credentials The Care App is an integral part of the Empatica Care remote health monitoring platform. It is intended for professional use and it is not designed to provide independent health tracking. Empatica is a pioneer in digital biomarker development and continuous patient monitoring driven by AI. Empatica makes medical-grade smartwatches, software, and digital biomarkers that can accurately monitor human health remotely, continuously, and unobtrusively, across a range of health conditions. EmbracePlus is CE-marked, and has been developed with key partners including HHS, USAMRDC, and the NASA-funded Translational Research Institute for Space Health.

The MyLongCOVID app is being used for a LongCOVID app and wearable study conducted by 4YouandMe - a digital health non-profit organization in partnership with the Patient Led Research Collaborative, and funded by the Chan Zuckerberg Initiative. This prototype app is 1 of 5 apps that are being tested as part of a larger rare and unique disease study that aims to co-design and pilot test symptom tracking and transmitting apps alongside wearable devices across 5 different conditions including Long COVID, Pancreatitis, Sarcoidosis, VCP disease and Primary Ciliary disease. Each of these conditions present unique symptom profiles across individuals that span symptoms of cognitive disturbances, pain, fatigue, cough, autonomic changes, respiration changes and mental health burden that are unique to each individual. This study aims to work with participants as co-designers to beta test an app and wearable experience that is intended to work like a compass to empower individuals to follow their unique symptom trajectories in passive and active ways, better understand what makes their condition better or worse and provide more accurate information for clinicians. If you decide to participate, after having a conversation with a 4YouandMe representative, you will download this study app where you will be fully informed of the study details and sign a consent form agreeing to participate. This app will serve as a hub for study participation. Using this app, you can track your study progress, complete surveys and tasks, and connect other mobile apps and wearable devices that will be provided to you that will include an Oura smartring, an Empatica EmbracePlus wrist band, and in some participants a Lumia ear device that tracks blood flow to the head. You will be asked to use the study app and wear the provisioned wearable devices for 5 months and communicate with a 4YouandMe Engagement Specialist every 2 weeks to discuss your experience. We expect that using the app for the study will take less than 5 minutes daily. This study has been reviewed and approved by an Institutional Review Board (Advarra).